| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |